September 7, 2017—The Senate Appropriations Committee approved legislation today that includes $10.2 million to run the 340B drug discount program in the new fiscal year that begins Oct. 1. In the report accompanying the bill, the committee urges the Office of Pharmacy Affairs, the Health Resources and Services Administration unit that administers the 340B program, to complete … [Read more...]
HRSA Holding Webinars on Revamped 340B Program Database
September 5, 2017—The Health Resources and Services Administration is holding separate introductory webinars next week for healthcare providers and drug manufacturers on its forthcoming replacement for the 340B drug discount program database. … [Read more...]
340B Is Good Conservative Policy
August 30, 2017—There’s been an uptick in editorials by conservative leaders across America on the 340B program’s importance as a lifeline for safety-net and rural hospitals. They rightfully warn federal policymakers not to let down their communities by curtailing 340B through misguided laws or regulations. Republican State Rep. Terri Funk Sypolt of the West Virginia House … [Read more...]
340B Hospitals Resilient as Hurricane Batters Texas and Louisiana
August 29, 2017—340B Health, the association of hospitals and health systems in the 340B drug discount program, expresses solidarity with its roughly 50 member hospitals in Texas and Louisiana and their staffs, families, and patients as they cope with the destruction and flooding wrought by Hurricane Harvey. Texas has been hit especially hard by the massive storm, which is … [Read more...]
Medicare Advisers Oppose Cutting 340B Hospitals’ Part B Drug Reimbursement
August 22, 2017—The Medicare Advisory Panel on Hospital Outpatient Payment has recommended that CMS not move forward with its July 20 proposed rule that would substantially reduce how much Medicare pays hospitals in the 340B drug discount program for separately payable Part B drugs under the Outpatient Prospective Payment System (OPPS). Medicare currently reimburses such drugs … [Read more...]
Mylan to Pay $19.3 Million Plus Interest for 340B Overcharges
August 18, 2017—Hospitals and other healthcare providers in the 340B drug discount program will receive $19.3 million plus interest from drug manufacturer Mylan for overcharges due to Mylan’s misclassification of its epinephrine auto-injector EpiPen as a generic rather than brand-name product. The 340B payment is part of Mylan’s $465 million settlement of a False Claims Act … [Read more...]
HRSA Updates Public About New 340B Info System
August 17, 2017—The Health Resources and Services Administration Office of Pharmacy Affairs posted an update on its website today about the registration component of its new 340B program information system, 340B OPAIS. “The 340B OPAIS will have two separate components – a new registration system and a new secure pricing system,” OPA said. “The registration component of the … [Read more...]